Wladimiro Jiménez Selected Research

Messenger RNA (mRNA)

1/2022	The pituitary tumour-transforming gene 1/delta-like homologue 1 pathway plays a key role in liver fibrogenesis.
3/2012	Prevention of fibrosis progression in CCl4-treated rats: role of the hepatic endocannabinoid and apelin systems.
10/2008	The hepatic apelin system: a new therapeutic target for liver disease.
11/2005	Microarray analysis of endothelial differentially expressed genes in liver of cirrhotic rats.
11/2004	Adrenomedullin messenger RNA expression is increased in myocardial tissue of patients with idiopathic dilated cardiomyopathy.
11/2002	Hypoxia is an inducer of vasodilator agents in peritoneal macrophages of cirrhotic patients.

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.

Realize the full power of the drug-disease research graph!

Wladimiro Jiménez Research Topics

Disease

49	Fibrosis (Cirrhosis) 01/2022 - 02/2002
19	Ascites 01/2016 - 02/2002
16	Liver Diseases (Liver Disease) 06/2022 - 01/2003
11	Liver Cirrhosis (Hepatic Cirrhosis) 01/2021 - 09/2003
10	Inflammation (Inflammations) 01/2022 - 07/2003
8	Portal Hypertension 10/2019 - 08/2003
8	Hepatorenal Syndrome 01/2019 - 03/2002
5	Infections 07/2014 - 08/2003
5	Hypoxia (Hypoxemia) 01/2013 - 11/2002
5	Renal Insufficiency (Renal Failure) 06/2005 - 11/2003
4	Necrosis 01/2019 - 10/2011
4	Heart Failure 04/2017 - 08/2004
3	Myocardial Infarction 01/2020 - 11/2016
3	Non-alcoholic Fatty Liver Disease 11/2019 - 01/2019
3	Neoplasms (Cancer) 04/2018 - 04/2010
3	ST Elevation Myocardial Infarction 04/2017 - 11/2016
3	Hyponatremia 12/2006 - 06/2003
3	Peritonitis 09/2005 - 08/2003
2	Fatty Liver 01/2019 - 01/2019
2	Acute Kidney Injury (Acute Renal Failure) 01/2019 - 01/2019
2	Ovarian Hyperstimulation Syndrome 03/2007 - 06/2002
2	Hypotension (Low Blood Pressure) 03/2004 - 01/2004
1	Pituitary Neoplasms (Pituitary Adenoma) 06/2022
1	Obesity 05/2021
1	Hyperlipidemias (Hyperlipidemia) 05/2021
1	Hepatocellular Carcinoma (Hepatoma) 10/2020
1	Cicatrix (Scar) 01/2020
1	Heart Diseases (Heart Disease) 07/2018
1	Osteoarthritis 07/2018
1	Atherosclerosis 07/2018

Drug/Important Bio-Agent (IBA)

13	Biomarkers (Surrogate Marker)IBA 01/2022 - 01/2010
8	ceric oxide (cerium dioxide)IBA 04/2021 - 03/2016
8	CollagenIBA 01/2021 - 08/2003
7	AntioxidantsIBA 05/2021 - 11/2005
6	Messenger RNA (mRNA)IBA 01/2022 - 11/2002
6	ApelinIBA 10/2019 - 10/2008
6	SodiumIBA 01/2016 - 02/2002
6	Carbon Tetrachloride (Tetrachloromethane)IBA 03/2013 - 02/2002
6	Vascular Endothelial Growth Factor A (Vascular Endothelial Growth Factor)IBA 01/2013 - 11/2002
5	CytokinesIBA 05/2021 - 06/2002
5	Peptides (Polypeptides)IBA 10/2019 - 03/2002
4	LipidsIBA 05/2021 - 01/2019
4	EndocannabinoidsIBA 10/2019 - 05/2005
4	Proteins (Proteins, Gene)FDA Link 03/2013 - 02/2002
3	Reactive Oxygen Species (Oxygen Radicals)IBA 04/2021 - 01/2019
3	GadoliniumIBA 01/2020 - 11/2016
3	CannabinoidsIBA 10/2019 - 02/2008
3	Lipocalin-2IBA 01/2019 - 08/2012
3	Vasopressins (Vasopressin)IBA 01/2016 - 10/2002
3	Vasoconstrictor AgentsIBA 01/2016 - 03/2002
3	CreatinineIBA 08/2012 - 09/2004
3	AlbuminsIBA 09/2005 - 10/2002
3	Norepinephrine (Noradrenaline)FDA LinkGeneric 08/2005 - 03/2002
3	ReninIBA 08/2005 - 11/2003
3	Prostaglandin-Endoperoxide Synthases (Cyclooxygenase)IBA 03/2005 - 01/2003
2	Therapeutic UsesIBA 01/2022 - 07/2018
2	Fatty Acids (Saturated Fatty Acids)IBA 01/2019 - 01/2019
2	Biological ProductsIBA 06/2016 - 07/2005
2	Angiopoietin-2IBA 04/2015 - 12/2007
2	Angiopoietin-1IBA 04/2015 - 12/2007
2	Matrix Metalloproteinases (MMPs)IBA 01/2013 - 08/2011
2	Collagen Type III (Type III Collagen)IBA 01/2013 - 08/2011
2	Intercellular Signaling Peptides and Proteins (Growth Factors)IBA 01/2013 - 12/2007
2	CB2 Cannabinoid ReceptorIBA 03/2012 - 02/2008
2	Angiotensin IIIBA 10/2011 - 07/2003
2	Apelin ReceptorsIBA 10/2011 - 10/2008
2	AntibodiesIBA 04/2010 - 02/2005
2	Nitric Oxide Synthase (NO Synthase)IBA 04/2005 - 06/2003
2	Nitric Oxide (Nitrogen Monoxide)FDA Link 04/2005 - 09/2004
2	Protein Isoforms (Isoforms)IBA 04/2005 - 03/2005
2	DiureticsIBA 03/2005 - 02/2002
2	Celecoxib (Celebrex)FDA Link 03/2005 - 02/2002
2	Furosemide (Lasix)FDA LinkGeneric 03/2005 - 02/2002
2	AdrenomedullinIBA 11/2004 - 11/2002
2	Tumor Necrosis Factor-alpha (Tumor Necrosis Factor)IBA 03/2004 - 11/2003
2	Endothelin-1 (Endothelin 1)IBA 01/2004 - 11/2002
1	clonidine-displacing substance (ClDS)IBA 06/2022
1	LigandsIBA 06/2022
1	Fatty Acid-Binding ProteinsIBA 01/2022
1	SolutionsIBA 05/2021
1	Superoxide DismutaseIBA 04/2021
1	Free RadicalsIBA 04/2021
1	EugenolIBA 04/2021
1	ResveratrolIBA 04/2021
1	Colchicine FDA LinkGeneric 04/2021
1	VitaminsIBA 04/2021
1	GoldIBA 01/2021
1	Arachidonic Acid (Vitamin F)IBA 10/2019
1	AcidsIBA 01/2019
1	Unsaturated Fatty Acids (Polyunsaturated Fatty Acids)IBA 01/2019
1	GraphiteIBA 12/2018
1	Metalloproteases (Metalloproteinases)IBA 12/2018
1	Dendrimers (Dendrons)IBA 12/2018
1	Tetradecanoylphorbol AcetateIBA 07/2018
1	ChondroitinIBA 07/2018
1	alpha-hydroxyglutarateIBA 04/2018

Therapy/Procedure

5	Therapeutics 12/2018 - 10/2002
3	Liver Transplantation 01/2014 - 06/2005
2	Oral Administration 11/2005 - 06/2003
1	Photothermal Therapy 01/2021